The National Institute on Drug Abuse (NIDA) at the National Institutes of Health is seeking exceptional candidates for the position of Director, Office of Translational Initiatives and Program Innovations (OTIPI). NIDA's mission is to lead the nation in bringing the power of science to bear on drug abuse and addiction. This charge has two critical components. The first is to advance translational research and innovation in the biomedical and health sciences. The second is to drive growth in biomedical and health sciences entrepreneurial communities in the area of addiction science, ensuring the rapid and effective dissemination of research results to improve practice and inform policy related to drug abuse and addiction. OTIPI is charged with maximizing NIH-funded basic and clinical science through the development of novel funding opportunities, product development, and entrepreneurial training. OTIPI partners with NIDA intramural and extramural divisions to accelerate the transition of research discoveries into new devices, diagnostics, drugs, and research tools. The Office supports a broad portfolio of grants, contracts, cooperative agreements, and prizes. Areas of scientific application include medications (drugs and biologics), devices, healthcare diagnostics, research tools, platform technologies, and health IT-based service and treatment research, all with high potential for translation. OTIPI is also responsible for NIDA’s partnership and funding activities with early-stage start-ups in industry-shifting technology areas (e.g., artificial intelligence, advanced manufacturing, digital health, virtual reality/augmented reality, data security, and gaming).
The Director of OTIPI reports to the NIDA Director and leads an institute-wide effort to (1) advance translational research and innovation in the biomedical and health sciences, and (2) drive growth in biomedical and health sciences entrepreneurial communities in area of addiction science. The OTIPI Director provides executive leadership and vision for trans-NIDA biomedical translation research programs. He/she formulates and implements plans and policies to carry out the OTIPI’s mission and oversees collaborative research efforts with other NIDA divisions, government agencies, and private industries. The OTIPI Director manages a total annual budget of $64M, which includes $48.7M for grants, $10M for translational programs, $4M for research and development contracts, $1.1M for research management and support, and $190K for novel funding authorities such as challenges and prize competitions. To carry out this work, the OTIPI Director manages six scientific staff, determines resource allocations, and manages staffing to ensure that mission goals are achieved. The OTIPI Director also serves as the lead NIDA representative to professional societies and the advocacy community by attending meetings and conferences, giving presentations to scientific and advocacy groups, and engaging in discussions with relevant stakeholders.
The NIDA seeks candidates who have a commitment to scientific excellence and the energy, enthusiasm, and innovative thinking necessary to assist in leading a dynamic and diverse organization. Applicants must possess an M.D. and/or Ph.D. or equivalent degree and should have research experience and national renown in a field that is relevant to drug abuse and addiction. In addition, he/she must possess experience that demonstrates the ability to manage and lead a large and diverse research program having national or international collaborations, scope, and impact. The OTIPI Director must also possess expertise in business development, excellent executive-level presentation and communication skills, and the ability to create and deliver high-profile presentations to a variety of internal and external audiences.
Telecommuting is allowed.
Additional Salary Information: The successful candidate for this position will be appointed at a salary commensurate with his/her qualifications. Full federal benefits will be provided including leave, health and life insurance, long-term care insurance, retirement, and savings plan (401k equivalent).
Internal Number: 22516
About National Institute on Drug Abuse
NIDA is the lead federal agency supporting scientific research on drug use and its consequences. Our mission is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health through:
Strategically supporting and conducting basic and clinical research on drug use (including nicotine), its consequences, and the underlying neurobiological, behavioral, and social mechanisms involved
Ensuring the effective translation, implementation, and dissemination of scientific research findings to improve the prevention and treatment of substance use disorders and enhance public awareness of addiction as a brain disorder
The strategic priorities outlined in this plan are intended to address the full breadth of complexity related to drug use and its health and social consequences across the spectrum, from occasional use to problematic use and substance use disorders (SUDs). SUDs include both behavioral and neurobiological components that are strongly influenced by diverse environmental and social factors. Advances in research technologies and informatics are helping us to understand the complex mediators of SUDs ...in unprecedented ways. NIDA’s strategic priorities for the next 5 years are designed to leverage these advances to translate our increasing understanding of the basic science of the brain and behavior into more effective prevention and treatment interventions that can ultimately reduce the negative impacts of drug use on society. To achieve this mission, NIDA will focus on advancing the following high-level strategic goals:
GOAL 1: Identify the biological, environmental, behavioral, and social causes and consequences of drug use and addiction across the lifespan
GOAL 2: Develop new and improved strategies to prevent drug use and its consequences
GOAL 3: Develop new and improved treatments to help people with substance use disorders achieve and maintain a meaningful and sustained recovery
GOAL 4: Increase the public health impact of NIDA research and programs